dehydroepiandrosterone has been researched along with Airflow Obstruction, Chronic in 3 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It was previously shown that dehydroepiandrosterone (DHEA) reverses chronic hypoxia-induced pulmonary hypertension (PH) in rats, but whether DHEA can improve the clinical and hemodynamic status of patients with PH associated to chronic obstructive pulmonary disease (PH-COPD) has not been studied whereas it is a very severe poorly treated disease." | 9.16 | Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study. ( Baulieu, EÉ; Billes, MA; Doutreleau, S; Dromer, C; Dumas de La Roque, E; Fayon, M; Jougon, J; Kraemer, JP; Marthan, R; Metivier, AC; Moore, N; Savineau, JP, 2012) |
| "It was previously shown that dehydroepiandrosterone (DHEA) reverses chronic hypoxia-induced pulmonary hypertension (PH) in rats, but whether DHEA can improve the clinical and hemodynamic status of patients with PH associated to chronic obstructive pulmonary disease (PH-COPD) has not been studied whereas it is a very severe poorly treated disease." | 5.16 | Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study. ( Baulieu, EÉ; Billes, MA; Doutreleau, S; Dromer, C; Dumas de La Roque, E; Fayon, M; Jougon, J; Kraemer, JP; Marthan, R; Metivier, AC; Moore, N; Savineau, JP, 2012) |
| "In patients with chronic obstructive pulmonary disease (COPD) weight loss frequently occurs that may ultimately lead to cachexia as a serious co-morbidity, indicating severely impaired functional capacity, health status and increased mortality." | 1.34 | Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement. ( Anker, SD; Doehner, W; Hoernig, S; John, M; Koehler, F; Witt, C, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karametos, I | 1 |
| Tsiboli, P | 1 |
| Togousidis, I | 1 |
| Hatzoglou, C | 1 |
| Giamouzis, G | 1 |
| Gourgoulianis, KI | 1 |
| Dumas de La Roque, E | 1 |
| Savineau, JP | 1 |
| Metivier, AC | 1 |
| Billes, MA | 1 |
| Kraemer, JP | 1 |
| Doutreleau, S | 1 |
| Jougon, J | 1 |
| Marthan, R | 1 |
| Moore, N | 1 |
| Fayon, M | 1 |
| Baulieu, EÉ | 1 |
| Dromer, C | 1 |
| Koehler, F | 1 |
| Doehner, W | 1 |
| Hoernig, S | 1 |
| Witt, C | 1 |
| Anker, SD | 1 |
| John, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double-blind, Randomised, Placebo-controlled Phase III Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults[NCT00581087] | Phase 3 | 60 participants (Anticipated) | Interventional | 2007-01-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dehydroepiandrosterone and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study.
Topics: Adult; Dehydroepiandrosterone; Exercise Test; Female; Hemodynamics; Humans; Hypertension, Pulmonary; | 2012 |
2 other studies available for dehydroepiandrosterone and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Chronic Obstructive Pulmonary Disease as a Main Factor of Premature Aging.
Topics: Aged; Aged, 80 and over; Aging, Premature; Biomarkers; Dehydroepiandrosterone; Female; Growth Hormon | 2019 |
Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
Topics: Anorexia; Appetite; Biomarkers; Body Mass Index; Cachexia; Dehydroepiandrosterone; Energy Metabolism | 2007 |